In asymptomatic patients with a pathogenic variant in one of the SDH genes, a lifelong screening is recommended as well, but without recommendation about the frequency of screening.11Thus, there is no clear approach for screening for head and neck paraganglioma in asymptomatic SDHx variant carriers. The gene discussed is SDHB; the disease is paraganglioma.